Open AccessAbstract 2902: Non-genetic TPX2/AURKA signaling facilitates tumor evolution in EGFR-TKI resistance in NSCLC
Author(s) -
Khyati N. Shah,
Roma Bhatt,
Julia Rotow,
Julia Rohrberg,
Victor Olivas,
Victoria E. Wang,
Jonathan Kuhn,
Sophie Dumont,
Frank McCormick,
Andrei Goga,
Collin M. Blakely,
Trever G. Bivona,
Sourav Bandyopadhyay
Publication year - 2019
Publication title -
cancer research
Language(s) - Uncategorized
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2019-2902
Subject(s) - osimertinib , cancer research , chromosome instability , drug resistance , somatic evolution in cancer , biology , genome instability , cancer , genetics , epidermal growth factor receptor , gene , erlotinib , dna , dna damage , chromosome